14Indexed trials
mesh condition
Status Epilepticus
Intelligence
Status Epilepticus intelligence: 14 indexed trials, 4 recruiting studies, 11 sponsors across 19 countries.
4Recruiting
11Sponsors
19Countries
Leading sponsors
Assistance Publique - Hôpitaux de Paris31 recruiting
Xuanwu Hospital, Beijing21 recruiting
Bio-Signal Group Corp.10 recruiting
Erasme University Hospital11 recruiting
Jie Liu10 recruiting
Marinus Pharmaceuticals10 recruiting
PTC Therapeutics10 recruiting
Sohag University11 recruiting
University of Milano Bicocca10 recruiting
ayesha tariq10 recruiting
Baptist Health South Florida10 recruiting
Geographic activity
United States4trials
France4trials
China3trials
Italy2trials
United Kingdom2trials
Egypt1trials
Finland1trials
Canada1trials
Germany1trials
Austria1trials
Japan1trials
Norway1trials
Leading interventions
Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel1trials
Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3)1trials
Blood sampling, cerebrospinal fluid, stool sampling post-mortem cerebral tissues (NA for the Group 3)1trials
Clonazepam1trials
Exogenous ketone ester1trials
Fosphenytoin1trials
IV Ganaxolone active1trials
IV Placebo, non-active1trials
Intravenous Sodium Valproate1trials
Ketamine1trials
Lorazepam1trials
Low frequency repeated TMS (LF-rTMS)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.